| Date Filed | Type | Description |
| 08/15/2023 |
3
| Dais Craig (CFO) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 07/17/2023 |
4
| Moss Dana J (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 250,000 shares
@ $0 |
|
| 07/17/2023 |
3
| Moss Dana J (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 06/30/2023 |
4
| Scott John K Jr. (10% Owner) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 12,200,000 shares
@ $0.088, valued at
$1.1M
|
|
| 06/15/2023 |
4
| Scott John K Jr. (10% Owner) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Disposed of 990 shares
@ $0
Granted 11,508,672 shares
@ $0
Bought 11,969 options to buy
@ $0.104, valued at
$1.2k
Converted 11,969 options to buy
@ $0.104, valued at
$1.2k
|
|
| 06/12/2023 |
4
| Stefanelli Jill (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 250,000 shares
@ $0 |
|
| 06/09/2023 |
3
| Stefanelli Jill (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 11/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2022 |
4
| Witter Malcolm G (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 10/04/2022 |
4
| CAPPELLO ALEXANDER L (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 10/04/2022 |
4
| Scott John K Jr. (10% Owner) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 10/04/2022 |
4
| Bhalla Amit (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 09/13/2022 |
4
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 28,150 shares
@ $0
Granted 13,000 shares
@ $0 |
|
| 09/01/2022 |
4
| Witter Malcolm G (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0
Bought 115 options to buy
@ $0.45, valued at
$51.8
Bought 115 options to buy
@ $0.5, valued at
$57.5 |
|
| 09/01/2022 |
4
| Scott John K Jr. (10% Owner) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0
Sold 1,740 options to buy
@ $0.8, valued at
$1.4k
Bought 2,400 options to buy
@ $0.45, valued at
$1.1k
Bought 2,400 options to buy
@ $0.5, valued at
$1.2k
|
|
| 09/01/2022 |
4
| CAPPELLO ALEXANDER L (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 09/01/2022 |
4
| Bhalla Amit (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 08/01/2022 |
4
| Witter Malcolm G (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 08/01/2022 |
4
| Scott John K Jr. (10% Owner) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 08/01/2022 |
4
| CAPPELLO ALEXANDER L (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 08/01/2022 |
4
| Bhalla Amit (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| CAPPELLO ALEXANDER L (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 shares
@ $0 |
|
|